The Efficacy of Factor VIIa in Emergency Department Patients With Warfarin Use and Traumatic Intracranial Hemorrhage

被引:36
|
作者
Nishijima, Daniel K. [1 ]
Dager, William E. [2 ]
Schrot, Rudolph J. [3 ]
Holmes, James F. [1 ]
机构
[1] UC Davis, Sch Med, Dept Emergency Med, Davis, CA 95616 USA
[2] UC Davis, Sch Med, Dept Pharm, Davis, CA USA
[3] UC Davis, Sch Med, Dept Neurosurg, Davis, CA USA
关键词
factor VII; traumatic intracranial hemorrhage; warfarin; ACTIVATED FACTOR-VII; RECOMBINANT-FACTOR-VIIA; ACUTE INTRACEREBRAL HEMORRHAGE; INJURY SEVERITY SCORE; BRAIN-INJURY; DOUBLE-BLIND; ANTICOAGULANT-THERAPY; CLINICAL-TRIAL; HEAD-INJURIES; REVERSAL;
D O I
10.1111/j.1553-2712.2010.00666.x
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objectives: The objective was to compare outcomes in emergency department (ED) patients with preinjury warfarin use and traumatic intracranial hemorrhage (tICH) who did and did not receive recombinant activated factor VIIa (rFVIIa) for international normalized ratio (INR) reversal. Methods: This was a retrospective before-and-after study conducted at a Level 1 trauma center, with data from 1999 to 2009. Eligible patients had preinjury warfarin use and tICH on cranial computed tomography (CT) scan. Patients before (standard cohort) and after (rFVIIa cohort) implementation of a protocol for administering 1.2 mg of rFVIIa in the ED were reviewed. Glasgow Coma Scale (GCS) score, Revised Trauma Score (RTS), Injury Severity Score (ISS), INR, and Marshall score were collected. Outcome measures included mortality, thromboembolic complications, and INR normalization. Results: Forty patients (median age = 80.5 years, interquartile range [IQR] = 63.5-85) were included (20 in each cohort). Age, GCS score, ISS, RTS, initial INR, and Marshall score were similar (p > 0.05) between the two cohorts. Survival was identical between cohorts (13 of 20, or 65.0%, 95% confidence interval [CI] = 40.8% to 84.6%). There were no differences in rate of thromboembolic complications in the standard cohort (1 of 20, 5.0%, 95% CI = 0.1% to 24.9%) than the rFVIIa cohort (4 of 20, 20.0%, 95% CI = 5.7% to 43.7%; p = 0.34). Time to normal INR was earlier in the rFVIIa cohort (mean = 4.8 hours, 95% CI = 3.0 to 6.7 hours) than in the standard cohort (mean = 17.5 hours, 95% CI = 12.5 to 22.6; p < 0.001). Conclusions: In patients with preinjury warfarin and tICH, use of rFVIIa was associated with a decreased time to normal INR. However, no difference in mortality was identified. Use of rFVIIa in patients on warfarin and tICH requires further study to demonstrate important patient-oriented outcomes. ACADEMIC EMERGENCY MEDICINE 2010; 17:244-251 (C) 2010 by the Society for Academic Emergency Medicine.
引用
收藏
页码:244 / 251
页数:8
相关论文
共 50 条
  • [41] Acute intracranial hemorrhage in a cirrhotic controlled with recombinant factor VIIa
    Mindikoglu, AL
    Anantharaju, A
    George, M
    Shah, NN
    Villanueva, J
    Van Thiel, DH
    DIGESTIVE DISEASES AND SCIENCES, 2003, 48 (06) : 1130 - 1135
  • [42] Use of recombinant factor VIIa in massive hemorrhage
    Baranovic, S.
    Rakaric-Poznanovic, M.
    NEUROLOGIA CROATICA, 2004, 53 : 109 - 112
  • [43] Dabigatran Use Does Not Increase Intracranial Hemorrhage in Traumatic Geriatric Falls When Compared with Warfarin
    Pozzessere, Anthony
    Grotts, Jonathan
    Kaminski, Stephen
    AMERICAN SURGEON, 2015, 81 (10) : 1039 - 1042
  • [45] Recombinant factor VIIa for the treatment of severe postoperative and traumatic hemorrhage
    Khan, AZ
    Parry, JM
    Crowley, WF
    McAllen, K
    Davis, AT
    Bonnell, BW
    Hoogeboom, JE
    AMERICAN JOURNAL OF SURGERY, 2005, 189 (03): : 331 - 334
  • [46] Emergency department and transport predictors of neurological deterioration in patients with spontaneous intracranial hemorrhage
    Bzhilyanskaya, Vera
    Najafali, Daniel
    Torre, Olivia M.
    Afridi, Leenah
    Cao, Tiffany
    Panchal, Bhakti
    Albelo, Fernando
    Karwoski, Allison
    Afridi, Ikram
    Tran, Quincy K.
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2022, 53 : 154 - 160
  • [47] Utility of infrascanner device in the diagnosis of intracranial hemorrhage in patients presenting to the emergency department
    Altuntas, Serkan
    Cetin, Ayse
    ANNALS OF CLINICAL AND ANALYTICAL MEDICINE, 2023, 14 (02): : 96 - 100
  • [48] Comparative hemostatic efficacy of 4F-PCC in patients with intracranial hemorrhage on factor Xa inhibitors versus warfarin
    Heath, Megan
    Hall, Brad
    De Leon, Jason
    Gillespie, Rita
    Hasara, Shannon
    Henricks, Bret
    Lakshmi, Magge
    Watson, Davin
    Wilson, Kayla
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2022, 57 : 149 - 152
  • [49] Fatal Intracranial Hemorrhage Associated with Oral Warfarin Use
    Jimenez-Ruiz, Amado
    Gutierrez-Castillo, Alejandro
    Luis Ruiz-Sandoval, Jose
    CUREUS, 2018, 10 (11):
  • [50] Traumatic Intracranial Hemorrhage in Geriatric Patients on Warfarin, Direct Oral Anticoagulants, or No Anticoagulation: A Prospective Study
    Alter, S. M.
    Solano, J. J.
    Engstrom, G.
    Shih, R. D.
    ANNALS OF EMERGENCY MEDICINE, 2020, 76 (04) : S37 - S37